Basics Monte Rosa Therapeutics, Inc. IPO Date: June 24, 2021 Sector: Healthcare Industry: Biotech Market Cap: $312.47M Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 4.25% Avg Daily Range (30 D): $0.16 | 3.52% Avg Daily Range (90 D): $0.20 | 3.86% Institutional Daily Volume Avg Daily Volume: .34M Avg Daily Volume (30 D): .39M Avg Daily Volume (90 D): .54M Trade Size Avg Trade Size (Sh.): 94 Avg Trade Size (Sh.) (30 D): 92 Avg Trade Size (Sh.) (90 D): 93 Institutional Trades Total Inst.Trades: 222 Avg Inst. Trade: $2.79M Avg Inst. Trade (30 D): $.63M Avg Inst. Trade (90 D): $.97M Avg Inst. Trade Volume: .3M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.91M Avg Closing Trade (30 D): $.53M Avg Closing Trade (90 D): $1.28M Avg Closing Volume: 250.93K     News Jun 10, 2025 @ 11:00 AM Monte Rosa Therapeutics Announces FDA Clearance of... Source: N/A Apr 28, 2025 @ 11:00 AM Monte Rosa Therapeutics Presents Preclinical Data ... Source: N/A Jan 6, 2025 @ 12:00 PM Monte Rosa Therapeutics to Present at the 43rd Ann... Source: N/A Dec 11, 2024 @ 12:00 PM Monte Rosa Therapeutics Presents Preclinical Data ... Source: N/A Nov 26, 2024 @ 12:00 PM Monte Rosa Therapeutics to Participate in the Pipe... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS Diluted EPS Revenue $ 159.49M $ 84.93M $ 60.65M Gross Profit $ $ $ Net Income / Loss $ 6.15M $ 46.89M $ 13.44M Operating Income / Loss $ -2.13M $ 44.04M $ 13M Cost of Revenue $ $ $ Net Cash Flow $ -21.21M $ -145.71M $ 98.63M PE Ratio